Blood Test Abbreviations: A Complete Reference Guide
Blood test reports are filled with abbreviations, acronyms, and codes that can seem opaque without a reference. This guide explains every common abbreviation you are likely to encounter — what each test measures, the units used, and the clinical context that determines how results are interpreted. Use the panel sections below to navigate by test type.
How to use this guide
Find the abbreviation from your report in the relevant panel section below. Each entry includes:
- Full name — what the abbreviation stands for
- What it measures — what the test actually quantifies in your blood
- Unit — how the result is expressed (note that units vary internationally)
- Clinical notes — context on what high or low values may suggest, and important caveats
A key principle: do not use reference ranges from this or any other website to interpret your specific result. Reference intervals are laboratory-specific and are printed on your own report. Use those ranges, not generic ones, for comparison.
Complete Blood Count (CBC)
The CBC is the most commonly ordered blood test. It measures the three major cell types in blood and a set of derived indices. See our full CBC interpretation guide for detailed guidance on reading this panel.
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| RBC | Red blood cell count | Number of red blood cells per unit volume of blood | × 10¹²/L or 10⁶/μL | Low RBC = anaemia; high RBC = polycythaemia. Interpret with Hgb and Hct. |
| Hgb / Hb | Haemoglobin | Concentration of the oxygen-carrying protein in red cells | g/dL or g/L | Primary marker for diagnosing anaemia. Men: ~13.5–17.5 g/dL; Women: ~12.0–15.5 g/dL. Ranges vary by lab. |
| Hct / PCV | Haematocrit / Packed cell volume | Proportion of blood volume occupied by red cells | % | Closely mirrors Hgb. Affected by hydration status. |
| MCV | Mean corpuscular volume | Average size of a red blood cell | fL | Low = microcytic (small cells; think iron deficiency, thalassaemia). High = macrocytic (large cells; think B12, folate, alcohol, liver disease). Normal = 80–100 fL approximately. |
| MCH | Mean corpuscular haemoglobin | Average amount of haemoglobin in a single red cell | pg | Usually tracks with MCV. Low in iron deficiency (hypochromic); high in macrocytic states. |
| MCHC | Mean corpuscular haemoglobin concentration | Haemoglobin concentration per unit volume of red cells | g/dL or g/L | Elevated MCHC (hyperchromia) is rare — seen in hereditary spherocytosis and with significant haemolysis. |
| RDW | Red cell distribution width | Variability in red cell size (anisocytosis) | % | High RDW + low MCV favours iron deficiency over thalassaemia trait. High RDW + high MCV with normal Hgb may indicate early B12/folate deficiency. |
| WBC | White blood cell count | Total number of white blood cells per unit volume | × 10⁹/L or 10³/μL | Interpret with the differential. Elevated in infection, inflammation, corticosteroids, stress. Low in some viral infections, certain medications, bone marrow disorders. |
| PLT | Platelet count | Number of platelet cell fragments per unit volume | × 10⁹/L or 10³/μL | Low (thrombocytopenia): bleeding risk if <50. High (thrombocytosis): often reactive (iron deficiency, inflammation). Very high may prompt haematology review. |
| Neut / ANC | Neutrophils / Absolute neutrophil count | Neutrophils — the main bacterial-fighting white cell | × 10⁹/L | High in bacterial infection, inflammation, corticosteroids. Low (neutropenia) increases infection susceptibility. Typical range: 1.8–7.5 × 10⁹/L. |
| Lymph | Lymphocyte count | Lymphocytes — key in viral immunity and antibody production | × 10⁹/L | High in viral infections (EBV, CMV, whooping cough), some leukaemias. Low in HIV, COVID-19, and some immunodeficiencies. |
| Mono | Monocyte count | Monocytes — phagocytic cells in chronic inflammation | × 10⁹/L | Elevated in chronic infections, inflammatory conditions, and post-infection recovery. |
| Eos | Eosinophil count | Eosinophils — active in allergy and parasitic infection | × 10⁹/L | Elevated in allergic conditions, asthma, eczema, drug reactions, and parasitic infections. |
| Baso | Basophil count | Basophils — rare WBCs involved in inflammatory reactions | × 10⁹/L | Rarely significantly elevated. Basophilia alongside other CBC abnormalities may indicate a myeloproliferative disorder. |
Metabolic Panels (CMP / BMP)
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| CBC | Complete blood count | Panel of tests measuring red cells, white cells, and platelets | — | The most commonly ordered blood test. Includes RBC, WBC, Hgb, Hct, MCV, MCH, MCHC, RDW, PLT, and often the WBC differential. |
| CMP | Comprehensive metabolic panel | 14-marker panel: glucose, electrolytes, kidney markers, liver enzymes, calcium | — | Includes: Glucose, BUN, Creatinine, eGFR, Sodium, Potassium, Chloride, CO₂, Calcium, Total protein, Albumin, Bilirubin, ALT, AST. |
| BMP | Basic metabolic panel | 8-marker panel: glucose, electrolytes, kidney markers (no liver enzymes) | — | A shorter version of the CMP, typically used for monitoring electrolytes and kidney function. |
| Na | Sodium | Main extracellular electrolyte; regulates fluid balance and nerve function | mmol/L or mEq/L | Low (hyponatraemia): vomiting, diuretics, heart failure, liver cirrhosis, SIADH. High (hypernatraemia): dehydration. Normal: approximately 135–145 mmol/L. |
| K | Potassium | Key electrolyte for muscle and heart function | mmol/L or mEq/L | Low (hypokalaemia): diuretics, vomiting, diarrhoea. High (hyperkalaemia): kidney disease, ACE inhibitors, beta-blockers, Addison's disease. Normal: approximately 3.5–5.0 mmol/L. |
| Cl | Chloride | Electrolyte that balances sodium and helps regulate acid-base status | mmol/L or mEq/L | Usually interpreted as part of the electrolyte panel rather than in isolation. Used to calculate the anion gap. |
| CO₂ / HCO₃ | Carbon dioxide / Bicarbonate | Approximate bicarbonate level; reflects acid-base balance | mmol/L or mEq/L | Low in metabolic acidosis (diabetic ketoacidosis, kidney disease, diarrhoea). High in metabolic alkalosis (vomiting, diuretics). Normal: approximately 22–29 mmol/L. |
| BUN | Blood urea nitrogen | Waste product from protein breakdown, cleared by kidneys | mg/dL or mmol/L | Elevated with reduced kidney function, dehydration, high protein intake, GI bleeding. Interpret with creatinine. |
| Cr / Creat | Creatinine | Muscle waste product cleared by kidneys; marker of kidney filtration | mg/dL or μmol/L | Elevated creatinine indicates reduced kidney filtration. Varies with muscle mass — a creatinine of 1.1 mg/dL in a small woman may represent significant dysfunction. Always consider alongside eGFR. |
| Ca | Calcium (total) | Total calcium in blood, including protein-bound fraction | mg/dL or mmol/L | Always interpret corrected for albumin (low albumin falsely lowers total Ca). Low = tetany risk; high = may indicate hyperparathyroidism, malignancy, or vitamin D toxicity. Normal total Ca: approximately 8.5–10.5 mg/dL (2.1–2.6 mmol/L). |
Electrolytes & Kidney Function
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| eGFR | Estimated glomerular filtration rate | Estimated rate at which the kidneys filter blood | mL/min/1.73m² | Calculated from creatinine, age, sex, and (in some equations) race. eGFR ≥90 = normal; 60–89 = mildly decreased; 30–59 = moderate CKD; 15–29 = severe; <15 = kidney failure. Interpret with clinical context; a single eGFR of 58 in isolation does not diagnose CKD (requires confirmation at ≥3 months). |
| Phos / PO₄ | Phosphate | Mineral important for bone health and energy metabolism | mg/dL or mmol/L | Elevated in kidney disease and hypoparathyroidism. Low in refeeding syndrome, malabsorption, hyperparathyroidism. |
| Mg | Magnesium | Mineral essential for muscle, nerve, and enzyme function | mg/dL or mmol/L | Commonly low in alcohol excess, diarrhoea, diuretic use, and malabsorption. Symptoms include muscle cramps and arrhythmia. Normal: approximately 1.7–2.2 mg/dL (0.7–0.9 mmol/L). |
Liver Function Tests (LFTs)
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| ALT / SGPT | Alanine aminotransferase | Enzyme present mainly in liver cells; leaks into blood when liver cells are damaged | U/L or IU/L | Most specific marker for hepatocellular damage. Elevated in hepatitis, fatty liver, alcohol, medication-induced liver injury. Normal: approximately 7–56 U/L, but ranges vary by lab and sex. |
| AST / SGOT | Aspartate aminotransferase | Enzyme found in liver, muscle, heart, and kidneys | U/L | Less specific than ALT for liver disease (also elevated in muscle injury and heart attack). ALT:AST ratio >2 in alcohol-related liver disease. Normal: approximately 10–40 U/L. |
| ALP / ALKP | Alkaline phosphatase | Enzyme in liver (bile ducts), bone, intestine, and placenta | U/L | Elevated in cholestatic liver disease (biliary obstruction, primary biliary cholangitis), bone disease (Paget's, bone metastases, fractures), and in normal pregnancy and growing children. Interpret alongside GGT to distinguish liver vs bone source. |
| GGT | Gamma-glutamyl transferase | Liver enzyme; sensitive marker of alcohol use and biliary disease | U/L | Elevated in alcohol use, cholestasis, fatty liver, and some medications. GGT + elevated ALP = biliary source likely. GGT can be elevated by medication (phenytoin, rifampicin) even without liver disease. |
| Bili / T.Bili | Bilirubin (total) | Yellow pigment from haemoglobin breakdown; processed by the liver | mg/dL or μmol/L | Elevated total bilirubin = jaundice. Conjugated (direct) bilirubin elevated in liver and biliary disease. Unconjugated elevated in haemolysis and Gilbert's syndrome (common, benign). Normal total: approximately 0.1–1.2 mg/dL (2–21 μmol/L). |
| TP | Total protein | Sum of albumin and globulins in the blood | g/dL or g/L | Low = malnutrition, liver disease, nephrotic syndrome. High = dehydration, chronic infection/inflammation (elevated globulins), paraprotein. Always interpret with albumin. |
Lipid Panel (Cholesterol)
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| TC | Total cholesterol | Sum of all cholesterol types in the blood | mg/dL or mmol/L | Used with LDL, HDL, and TG to assess cardiovascular risk. No single target applies to everyone — risk depends on other factors. Fasting usually preferred but non-fasting acceptable for initial screening. |
| LDL | Low-density lipoprotein cholesterol | Cholesterol carried in LDL particles ('bad' cholesterol) | mg/dL or mmol/L | Primary target in cardiovascular risk management. Target LDL varies significantly by individual risk category — <70 mg/dL (1.8 mmol/L) for very high risk; <100 mg/dL for high risk; discuss your target with your clinician. |
| HDL | High-density lipoprotein cholesterol | Cholesterol carried in HDL particles ('good' cholesterol) | mg/dL or mmol/L | Higher HDL is generally protective. Low HDL is a cardiovascular risk factor. Typical low thresholds: <40 mg/dL (1.0 mmol/L) in men; <50 mg/dL (1.3 mmol/L) in women — but these are guides, not firm targets. |
| TG / TRIG | Triglycerides | Blood fats measured after fasting; elevated by recent food, alcohol, and certain conditions | mg/dL or mmol/L | Significantly affected by fasting status. Elevated in insulin resistance, metabolic syndrome, alcohol excess, hypothyroidism, renal disease, some medications. Very high TG (>500 mg/dL) raises pancreatitis risk. Normal fasting: <150 mg/dL (<1.7 mmol/L). |
| Non-HDL-C | Non-HDL cholesterol | Total cholesterol minus HDL — includes LDL and VLDL | mg/dL or mmol/L | Increasingly used as a cardiovascular risk marker, particularly when triglycerides are elevated (making LDL calculation less reliable). Non-HDL = Total cholesterol − HDL. |
| Lp(a) | Lipoprotein (a) | Genetically determined lipoprotein that independently increases cardiovascular risk | mg/dL or nmol/L | Not routinely measured in all guidelines. High Lp(a) is a heritable risk factor largely unaffected by lifestyle. Currently no widely approved pharmacological treatment, though PCSK9 inhibitors reduce it modestly. |
Thyroid
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| TSH | Thyroid-stimulating hormone | Pituitary hormone that controls thyroid function; primary thyroid screening marker | mIU/L or μIU/mL | Primary screening test for thyroid dysfunction. High TSH = underactive thyroid (hypothyroidism). Low TSH = overactive (hyperthyroidism). Typical range: 0.4–4.0 mIU/L, but ranges and interpretation vary in pregnancy and with certain medications. Always interpret with symptoms. |
| FT4 / Free T4 | Free thyroxine | The biologically active fraction of T4 hormone produced by the thyroid | pmol/L or ng/dL | Measured when TSH is abnormal or thyroid disease is suspected. Low FT4 with high TSH = primary hypothyroidism. Low FT4 with low TSH = central hypothyroidism. Interpret in context of TSH. |
| FT3 / Free T3 | Free triiodothyronine | The most biologically active thyroid hormone | pmol/L or pg/mL | Not routinely ordered in primary screening. Used in suspected T3 thyrotoxicosis, monitoring thyroid disease, and after thyroidectomy. Levels can be suppressed in serious non-thyroidal illness ('sick euthyroid syndrome'). |
| Anti-TPO | Anti-thyroid peroxidase antibodies | Antibodies against thyroid peroxidase enzyme; marker of autoimmune thyroid disease | IU/mL | Elevated in Hashimoto's thyroiditis and Graves' disease. Positive Anti-TPO with a normal TSH may indicate increased risk of future hypothyroidism. Not required for routine thyroid screening. |
Diabetes & Glucose
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| Glu / FBS | Glucose / Fasting blood sugar | Blood sugar concentration (usually measured fasting) | mg/dL or mmol/L | Fasting normal: 70–99 mg/dL (3.9–5.5 mmol/L). Prediabetes: 100–125 mg/dL. Diabetes: ≥126 mg/dL on two occasions. Post-meal (2h) targets differ. Interpret with HbA1c. |
| HbA1c / A1C | Glycated haemoglobin | Estimate of average blood glucose over the preceding approximately 8–12 weeks | % or mmol/mol (IFCC) | Used to diagnose and monitor diabetes. <5.7% (39 mmol/mol) = normal. 5.7–6.4% (39–47) = prediabetes. ≥6.5% (48) on two occasions = diabetes. Affected by conditions that alter red cell lifespan (haemolytic anaemia, recent blood transfusion can give falsely low values). |
| OGTT | Oral glucose tolerance test | Blood glucose measured fasting and 2 hours after a 75 g glucose drink | mg/dL or mmol/L | More sensitive than fasting glucose for detecting impaired glucose tolerance. Standard diagnostic test in pregnancy (gestational diabetes screening). Two-hour value ≥200 mg/dL (11.1 mmol/L) = diabetes. |
| Insulin / Fasting insulin | Fasting insulin | Level of insulin in blood after overnight fast | μIU/mL or pmol/L | Not a routine screening test but used to assess insulin resistance (often with fasting glucose in the HOMA-IR calculation). Elevated fasting insulin with normal glucose indicates insulin resistance before frank diabetes develops. |
Iron Studies
See our detailed ferritin levels guide for a full explanation of how these tests work together.
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| Fe / Serum iron | Serum iron | Iron currently circulating in blood, bound to transferrin | μg/dL or μmol/L | Varies significantly with time of day (highest in morning), recent meals, inflammation, and menstruation. A single low serum iron does not diagnose iron deficiency — interpret with TSAT and ferritin. |
| TIBC | Total iron-binding capacity | Total capacity of transferrin to carry iron | μg/dL or μmol/L | Elevated TIBC in iron deficiency (transferrin upregulated). Low TIBC in inflammation, liver disease, protein malnutrition. Used to calculate transferrin saturation. |
| TSAT | Transferrin saturation | Percentage of transferrin currently bound to iron | % | TSAT = (Serum iron ÷ TIBC) × 100. Low TSAT (<16–20%) with low ferritin = iron deficiency. Low TSAT with normal/high ferritin = anaemia of chronic disease. High TSAT (>45–50%) with high ferritin = possible iron overload (haemochromatosis). |
| Ferritin | Serum ferritin | Indirect estimate of total body iron stores | ng/mL or μg/L | Most useful marker for diagnosing iron deficiency (low ferritin is highly specific). However, ferritin is an acute-phase reactant — it rises with inflammation, infection, and liver disease, potentially masking true iron deficiency. See the ferritin guide for more detail. |
Vitamins, Minerals & Inflammation
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| Vit D / 25-OH-D | 25-hydroxyvitamin D | The storage form of vitamin D; reflects overall vitamin D status | ng/mL or nmol/L | Deficiency <20 ng/mL (<50 nmol/L) by most guidelines. Insufficiency 20–29 ng/mL. Units differ: 1 ng/mL = 2.5 nmol/L. Note that 1,25-dihydroxyvitamin D (the active form) is a different test and not routinely used to assess vitamin D status. |
| B12 / Cobalamin | Vitamin B12 | Level of vitamin B12 in serum | pg/mL or pmol/L | Normal range varies (commonly 200–900 pg/mL). Serum B12 has significant variability. Low B12 is associated with macrocytic anaemia, neuropathy, and cognitive effects. Methylmalonic acid (MMA) and homocysteine are more sensitive markers of functional B12 deficiency when serum B12 is borderline. |
| Folate / Folic acid | Serum folate (or RBC folate) | B9 vitamin level in blood | ng/mL or nmol/L | Serum folate reflects recent intake; RBC folate reflects longer-term status. Deficiency causes macrocytic anaemia. Essential before and during pregnancy to prevent neural tube defects. Often low in alcohol excess and malabsorption. |
| CRP | C-reactive protein | Acute-phase protein produced by the liver in response to inflammation or infection | mg/L | Rises rapidly (within hours) and falls quickly when inflammation resolves. High-sensitivity CRP (hsCRP) is used in cardiovascular risk stratification. Elevated CRP is non-specific — it does not identify the cause of inflammation. |
| ESR | Erythrocyte sedimentation rate | Rate at which red cells settle in a test tube; indirect marker of inflammation | mm/hr | ESR is slower to rise and fall than CRP. Normal values increase with age. Often used alongside CRP in monitoring inflammatory conditions like rheumatoid arthritis, polymyalgia rheumatica, and giant cell arteritis. |
| Uric acid / UA | Uric acid / Urate | End-product of purine metabolism excreted by the kidneys | mg/dL or μmol/L | Elevated in gout, renal impairment, high purine diet, alcohol, diuretics. A single elevated uric acid does not diagnose gout — clinical features (acute joint inflammation) are essential for diagnosis. |
| PSA | Prostate-specific antigen | Protein produced by prostate cells; marker used in prostate cancer screening and monitoring | ng/mL | Elevated PSA can result from prostate cancer but also from benign prostatic hyperplasia (BPH), prostatitis, and recent prostate manipulation. PSA screening decisions should be made with your clinician, considering individual risk and preferences. |
Cardiac & Coagulation
| Abbreviation | Full name | What it measures | Unit | Clinical notes |
|---|---|---|---|---|
| LDH | Lactate dehydrogenase | Enzyme found in many tissues; released when cells are damaged | U/L | Non-specific — elevated in haemolysis, liver disease, muscle injury, heart attack, and some cancers. Most useful in specific contexts: very high in haematological malignancies; elevated in haemolysis alongside other haemolysis markers. |
| CK / CPK | Creatine kinase / Creatine phosphokinase | Enzyme found predominantly in muscle cells; released in muscle damage | U/L | Elevated after strenuous exercise, muscle trauma, rhabdomyolysis, myocardial infarction (CK-MB isoform), or inflammatory myopathy. Exercise can significantly elevate CK for 24–72 hours. |
| Troponin | Troponin I or Troponin T | Heart muscle protein released into blood during myocardial cell death | ng/L or ng/mL | High-sensitivity troponin assays have largely replaced older tests. Elevated troponin in the context of chest pain strongly suggests myocardial infarction. Can also be elevated in myocarditis, pulmonary embolism, sepsis, and renal failure (chronic elevation). |
| INR | International normalised ratio | Standardised measure of how long blood takes to clot (extrinsic pathway) | ratio (unitless) | Normal INR for someone not on anticoagulants: approximately 0.8–1.2. Elevated in warfarin treatment (target typically 2–3), liver disease, vitamin K deficiency. A high INR in someone not on anticoagulants requires investigation. |
| aPTT / APTT | Activated partial thromboplastin time | Clotting time measuring the intrinsic coagulation pathway | seconds | Prolonged aPTT seen with heparin therapy, haemophilia A/B, and factor deficiencies. Often ordered with INR/PT as part of a coagulation screen. |
| D-dimer | D-dimer | Fibrin degradation product formed when a blood clot breaks down | mg/L FEU or ng/mL | Highly sensitive but not specific for clot (DVT, PE). A negative D-dimer in a low pre-test probability setting helps exclude clot. Elevated D-dimer is common in infection, inflammation, pregnancy, recent surgery, and cancer — does not confirm a clot. |
Related educational guides
Trusted reference sources
- MedlinePlus: Laboratory tests (U.S. National Library of Medicine)
- NHS: Blood tests
- Mayo Clinic: Blood tests
- Lab Tests Online (American Association for Clinical Chemistry)
See your abbreviations explained automatically
Upload your blood test report and our AI will identify every abbreviation, explain what it measures, and flag values outside the reference interval for your review.
Analyze my blood test →